U.S. regulator charges two with insider trading in Abbott deal
December 22, 2014 at 14:32 PM EST
NEW YORK/SANTIAGO, Dec 22 (Reuters) - A former board member of Chile's CFR Pharmaceuticals SA was charged Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories' $2.9 billion acquisition of CFR earlier this year.
